Daniel R. Waldo

1.4k total citations
27 papers, 1.1k citations indexed

About

Daniel R. Waldo is a scholar working on General Health Professions, Economics and Econometrics and Demography. According to data from OpenAlex, Daniel R. Waldo has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in General Health Professions, 18 papers in Economics and Econometrics and 5 papers in Demography. Recurrent topics in Daniel R. Waldo's work include Healthcare Policy and Management (18 papers), Global Health Care Issues (13 papers) and Primary Care and Health Outcomes (6 papers). Daniel R. Waldo is often cited by papers focused on Healthcare Policy and Management (18 papers), Global Health Care Issues (13 papers) and Primary Care and Health Outcomes (6 papers). Daniel R. Waldo collaborates with scholars based in United States, United Kingdom and Italy. Daniel R. Waldo's co-authors include Helen C. Lazenby, Katharine R. Levit, Robert Gibson, David McKusick, Mark S. Freeland, George S. Chulis, R H Arnett, Cathy A. Cowan, Gerald Adler and Suzanne W. Letsch and has published in prestigious journals such as Annals of Internal Medicine, Health Affairs and Journal of Health Care for the Poor and Underserved.

In The Last Decade

Daniel R. Waldo

27 papers receiving 863 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel R. Waldo United States 17 610 585 99 77 70 27 1.1k
Stephen Heffler United States 14 590 1.0× 656 1.1× 58 0.6× 65 0.8× 72 1.0× 24 1.1k
Helen C. Lazenby United States 23 920 1.5× 864 1.5× 133 1.3× 111 1.4× 92 1.3× 27 1.5k
Mark R. Meiners United States 12 421 0.7× 378 0.6× 79 0.8× 71 0.9× 90 1.3× 26 840
Mark McClellan United States 6 526 0.9× 581 1.0× 80 0.8× 89 1.2× 50 0.7× 9 839
Chapin White United States 17 720 1.2× 693 1.2× 62 0.6× 69 0.9× 61 0.9× 57 1.0k
Nelda McCall United States 17 774 1.3× 674 1.2× 61 0.6× 85 1.1× 59 0.8× 41 960
Sandra García-Armesto Spain 12 513 0.8× 343 0.6× 55 0.6× 87 1.1× 81 1.2× 28 865
Heidi Whitmore United States 23 819 1.3× 895 1.5× 74 0.7× 48 0.6× 69 1.0× 65 1.2k
Cynthia Smith United States 10 381 0.6× 439 0.8× 45 0.5× 35 0.5× 48 0.7× 14 737
Mark S. Freeland United States 17 535 0.9× 551 0.9× 101 1.0× 51 0.7× 27 0.4× 30 824

Countries citing papers authored by Daniel R. Waldo

Since Specialization
Citations

This map shows the geographic impact of Daniel R. Waldo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel R. Waldo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel R. Waldo more than expected).

Fields of papers citing papers by Daniel R. Waldo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel R. Waldo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel R. Waldo. The network helps show where Daniel R. Waldo may publish in the future.

Co-authorship network of co-authors of Daniel R. Waldo

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel R. Waldo. A scholar is included among the top collaborators of Daniel R. Waldo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel R. Waldo. Daniel R. Waldo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kronick, Richard, et al.. (2025). Are Fewer Diagnoses Better? Assessing A Proposal To Improve The Medicare Advantage Payment System. Health Affairs. 44(1). 66–74. 2 indexed citations
2.
Dave, Kuldip D., Björn Oskarsson, Terry Heiman‐Patterson, et al.. (2024). Contributions of neurologists to diagnostic timelines of ALS and thinkALS as an early referral instrument for clinicians. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 26(3-4). 215–224. 3 indexed citations
3.
Waldo, Daniel R.. (2018). National Health Accounts: A Framework For Understanding Health Care Financing. Health Affairs. 37(3). 498–503. 4 indexed citations
4.
Frankenfield, Diane L., et al.. (2010). Prescription Medication Cost-Related Non-adherence among Medicare CAHPS Respondents: Disparity by Hispanic Ethnicity. Journal of Health Care for the Poor and Underserved. 21(2). 518–543. 21 indexed citations
5.
Waldo, Daniel R.. (2004). Symptoms of depression among aged Medicare enrollees: 2002.. PubMed. 26(1). 143–55. 4 indexed citations
6.
Waldo, Daniel R.. (2004). Accuracy and Bias of Race/Ethnicity Codes in the Medicare Enrollment Database.. PubMed. 26(2). 61–72. 67 indexed citations
7.
Waldo, Daniel R., et al.. (1995). Access to physicians.. PubMed. 17(2). 243–8. 6 indexed citations
8.
Waldo, Daniel R., et al.. (1995). National health expenditure projections, 1994-2005.. PubMed. 16(4). 221–42. 191 indexed citations
9.
Waldo, Daniel R.. (1994). Estimating the cost of a Medicare outpatient prescription drug benefit.. PubMed. 15(3). 103–12. 2 indexed citations
10.
Chulis, George S., et al.. (1993). Health Insurance and the Elderly. Health Affairs. 12(1). 111–118. 21 indexed citations
11.
Waldo, Daniel R., et al.. (1991). Projections of national health expenditures through the year 2000.. PubMed. 13(1). 1–15. 68 indexed citations
12.
Waldo, Daniel R., et al.. (1991). U.S./Canadian Health Spending: Methods And Assumptions. Health Affairs. 10(2). 159–164. 7 indexed citations
13.
Waldo, Daniel R., et al.. (1991). Health Spending Through 2030: Three Scenarios. Health Affairs. 10(4). 231–242. 9 indexed citations
14.
Levit, Katharine R., Mark S. Freeland, & Daniel R. Waldo. (1990). National Health Care Spending Trends: 1988. Health Affairs. 9(2). 171–184. 35 indexed citations
15.
Waldo, Daniel R.. (1987). Outpatient prescription drug spending by the Medicare population.. PubMed. 9(1). 83–9. 12 indexed citations
16.
Waldo, Daniel R., Katharine R. Levit, & Helen C. Lazenby. (1986). National health expenditures, 1985.. PubMed. 8(1). 1–21. 66 indexed citations
17.
Waldo, Daniel R. & Helen C. Lazenby. (1984). Demographic characteristics and health care use and expenditures by the aged in the United States: 1977-1984.. PubMed. 6(1). 1–29. 72 indexed citations
18.
Gibson, Robert, Katharine R. Levit, Helen C. Lazenby, & Daniel R. Waldo. (1984). National health expenditures, 1983.. PubMed. 6(2). 1–29. 67 indexed citations
19.
Gibson, Robert & Daniel R. Waldo. (1981). National health expenditures, 1980.. PubMed. 3(1). 1–54. 54 indexed citations
20.
Gibson, Robert, Daniel R. Waldo, & Katharine R. Levit. (1973). National health expenditures, 1982.. PubMed. 37(1). 1–1449. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026